Rare liver disease study could change how doctors treat dangerous complications
NCT ID NCT07163689
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at a rare liver condition called Porto-Sinusoidal Vascular Disease (PSVD), which causes high blood pressure in the liver's veins. Researchers want to see if a procedure called TIPS works as well for PSVD patients as it does for those with cirrhosis. They will compare survival and complication rates in 360 patients from French hospitals, using existing medical records.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors decide when to use TIPS for patients with PSVD, potentially improving survival and reducing complications.
- What could go wrong
- This is an observational study, not a trial of a new treatment. It may not provide definitive answers due to its retrospective design and small number of PSVD cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Amiens Picardie
RECRUITINGAmiens, Picardie, 80054, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can everyday drugs shield the liver from Cirrhosis's worst threats?
- Can extra doses of an old drug reverse liver scarring?
- Medical glue vs. internal bleeding: a new hope?
- A painless spleen scan could spot deadly vein bleeding risk without endoscopy
- Could a common gut drug clear the way for life-saving endoscopy?
- Could a yellow tinge predict dangerous hospital infections?